Focus: Autonomous Therapeutics is a Rockville-based biotech focused on nucleic acid medicines and in vivo research across virology and cancer biology, with a mission of evolving therapeutics for lifelong protection. Company scale and founding details are not publicly disclosed.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
High-risk, high-reward pre-revenue play suitable only for scientists willing to bet on unproven platform technology and tolerant of transparency gaps and minimal near-term hiring.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Autonomous Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Autonomous Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo